Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Monopar Therapeutics Inc (NQ: MNPR )

3.365 +0.205 (+6.49%)
Streaming Delayed Price Updated: 9:49 AM EST, Feb 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,527
Open 3.360
Bid (Size) 3.360 (1)
Ask (Size) 3.390 (1)
Prev. Close 3.160
Today's Range 3.360 - 3.380
52wk Range 1.391 - 4.880
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Monopar Announces Projected Timeline of Upcoming Q1 2023 Data Events for Validive, Camsirubicin, and MNPR-101 RIT
From Monopar Therapeutics Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
 
Via Benzinga

Performance

YTD
+45.05%
+45.05%
1 Month
+45.05%
+45.05%
3 Month
+14.46%
+14.46%
6 Month
+69.96%
+69.96%
1 Year
+14.85%
+14.85%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2
From Monopar Therapeutics Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Monopar Announces Promising MNPR-202 Data from Ongoing National University of Singapore Collaboration
From Monopar Therapeutics Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Monopar Therapeutics Highlights Encouraging Data From Early-Stage Soft Tissue Cancer Study
Via Benzinga
Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial
From Monopar Therapeutics Inc.
Via Globe NewsWire
Monopar Therapeutics Reports Third Quarter 2022 Financial Results and Recent Program Developments
From Monopar Therapeutics Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Monopar Announces Timeline of Upcoming Data Events for Validive, Camsirubicin, and MNPR-202
From Monopar Therapeutics Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.